Eupraxia Pharmaceuticals is trading 15.4% higher at $7.94, with no confirmed company-specific announcement explaining the pre-market move.
- The November 3 close was $6.88.
- Nasdaq’s page showed no updates available.
- Healthcare was up 1.55% pre-market; it may be contributing, but this does not establish a direct cause for the stock’s larger move.